William Kinnebrew
Family Medicine · Shreveport, LANPI 1831170984
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 245 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,834 and has fallen 71.3% since, to $526 in 2021.
Across 245 payments — averaging $14.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$659
- Merck$390
- Novo Nordisk$318
- Pfizer$314
- Amarin Pharma, Inc.$245
- Boehringer Ingelheim$208
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,568100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 42 | $659 |
| Merck | 27 | $390 |
| Novo Nordisk | 23 | $318 |
| Pfizer | 21 | $314 |
| Amarin Pharma, Inc. | 15 | $245 |
| Boehringer Ingelheim | 15 | $208 |
| AbbVie(2 entities) | 24 | $183 |
| Sanofi-aventis U.S. LLC | 11 | $178 |
| GSK | 12 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $158 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $146 |
| Lilly USA, LLC | 8 | $123 |
| Kowa Pharmaceuticals America, Inc. | 7 | $109 |
| Amgen | 4 | $73 |
| Johnson & Johnson | 4 | $53 |
| Shire North American Group Inc | 3 | $51 |
| Daiichi Sankyo Inc. | 2 | $50 |
| Mylan Specialty L.p. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $27 |
| Esperion Therapeutics, Inc. | 2 | $26 |
| Abbott | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Novartis | 1 | $13 |
How this compares
$3,574 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Louisiana.
Other family medicine in Shreveport
- Michael FlemingShreveport$165K
- Krishna SinghShreveport$22K
- Larry FlakeShreveport$20K
- Russell CarrShreveport$17K
- Richard KammShreveport$17K
- Wendy MosesShreveport$16K
- William GibsonShreveport$13K
- Christine SmithBaton Rouge$185K
- Thomas DansbyMonroe$169K
- Robert St AmantGonzales$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.